Author + information
- Satyajit Reddya,b,
- Vladimir Lakhtera,b,
- Chad Zacka,b,
- Saurav Chatterjeea,b,
- Vikas Aggarwala,b and
- Riyaz Bashira,b
Introduction: Inferior vena cava filter (IVCF) placement is a common clinical practice in the United States (US). Given the growing concerns over IVCF-related complications, the US Food and Drug Administration (FDA) issued an advisory in 2010. The contemporary nationwide trends in the utilization of IVCF and the effect of the FDA advisory are unknown.
Methods: The Nationwide Inpatient Sample (NIS) database was used to identify all patients over 18 years of age who underwent IVCF placement in the US between January 2005 and December 2013. The annual rate of IVCF placement (per 100,000 US population) was then calculated using the US population census for the given year. Cochrane-Armitage trend test was used to evaluate the trends of IVCF use before (2005 to 2010) and after (2010 to 2013) the FDA advisory.
Results: Between January 2005 and December 2013, a total of 1,039,941 IVCFs were placed in the US (national estimates). There was a 29% increase in IVCF use from 2005 to 2010 (from 45 to 55/100,000 population: p<0.01), while a 22% decrease was noted after the FDA advisory (from 55 to 42/100,000 population: p< 0.01) (see figure).
Conclusions: This nationwide observational study showed that IVCF utilization rates in the US continue to be very high, however the 2010 FDA advisory has significantly and successfully blunted this trend.
Poster Hall, Hall C
Friday, March 17, 2017, 10:00 a.m.-10:45 a.m.
Session Title: Head to Toe: Outcomes of Endovascular Interventions
Abstract Category: 18. Interventional Cardiology: Carotid and Endovascular Intervention
Presentation Number: 1112-128
- 2017 American College of Cardiology Foundation